Based on the analysis of Ingevity Corp's profitability, liquidity, and operating efficiency, Ingevity Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Ingevity Corp's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 102.2 M in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 884.8 M in 2024. Key indicators impacting Ingevity Corp's financial strength include:
The essential information of the day-to-day investment outlook for Ingevity Corp includes many different criteria found on its balance sheet. An individual investor should monitor Ingevity Corp's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Ingevity Corp.
Net Income
(5.13 Million)
Ingevity
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Dividends Paid
Change Receivables
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Common Stock Shares Outstanding
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Good Will
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Accumulated Other Comprehensive Income
Intangible Assets
Common Stock
Other Liab
Net Tangible Assets
Current Deferred Revenue
Other Assets
Long Term Debt
Short Long Term Debt
Short Term Debt
Property Plant Equipment
Retained Earnings
Long Term Debt Total
Deferred Long Term Liab
Retained Earnings Total Equity
Short Term Investments
Capital Surpluse
Long Term Investments
Treasury Stock
Non Current Liabilities Other
Net Invested Capital
Net Working Capital
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Net Income From Continuing Ops
Net Income Applicable To Common Shares
Minority Interest
Tax Provision
Non Recurring
Net Interest Income
Interest Income
Non Operating Income Net Other
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Ingevity Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ingevity Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Ingevity Corp's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Ingevity Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ingevity Corp. Check Ingevity Corp's Beneish M Score to see the likelihood of Ingevity Corp's management manipulating its earnings.
Ingevity Corp Stock Summary
Ingevity Corp competes with H B, Minerals Technologies, Quaker Chemical, Oil Dri, and Sensient Technologies. Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina. Ingevity Corp operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 1850 people.
The reason investors look at the income statement is to determine what Ingevity Corp's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Ingevity Corp's current stock value. Our valuation model uses many indicators to compare Ingevity Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ingevity Corp competition to find correlations between indicators driving Ingevity Corp's intrinsic value. More Info.
Ingevity Corp is rated below average in return on equity category among its peers. It is regarded third in return on asset category among its peers . At this time, Ingevity Corp's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Ingevity Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Ingevity Corp Systematic Risk
Ingevity Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ingevity Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Ingevity Corp correlated with the market. If Beta is less than 0 Ingevity Corp generally moves in the opposite direction as compared to the market. If Ingevity Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ingevity Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ingevity Corp is generally in the same direction as the market. If Beta > 1 Ingevity Corp moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Ingevity Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ingevity Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ingevity Corp growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Ingevity Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ingevity Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ingevity Corp based on widely used predictive technical indicators. In general, we focus on analyzing Ingevity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ingevity Corp's daily price indicators and compare them against related drivers.
When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.